Virtual Science AI Unveils Real-Time Medical Congress AI, Redefining Event Intelligence in Life Sciences
LONDON: Life science technology firm Virtual Science AI has launched Medical Congress AI, the industry’s first artificial intelligence solution designed to capture and analyse medical congress interactions in real time.
The platform represents a major shift in how pharmaceutical and biotechnology companies collect, process, and utilise scientific intelligence from global medical events.
According to the company, Medical Congress AI was developed to address long-standing inefficiencies associated with manual reporting, delayed analysis, and costly third-party data aggregation.
Replacing Outdated Reporting Methods
Traditionally, professionals attending medical congresses were required to complete detailed reports after each session, often late at night, before submitting them for further processing.
This approach was time-consuming, expensive, and vulnerable to human error, resulting in the loss of valuable insights.
With Medical Congress AI, users can now record and analyse key discussions instantly, allowing emerging trends, critical topics, and scientific priorities to be identified in near real time.
The system also integrates congress data with internal company databases, offering a comprehensive and actionable view of market dynamics.
Leadership Highlights Industry Impact
Chief Executive Officer Tom Hughes said the solution ensures that important findings are no longer delayed or overlooked.
“Medical congresses are essential for scientific progress, but too often insights fail to reach decision-makers in time. Our platform ensures seamless capture and same-day delivery of intelligence,” he said.
Meanwhile, Chief Customer Officer Geraldine Reilly described the system as a transformative tool for industry professionals.
“It eliminates the pressure of recalling every conversation after a long day. Nothing important is lost,” she added.
Accelerating Research and Market Strategy
Industry analysts believe Medical Congress AI could significantly improve decision-making in drug development, clinical research, and commercial strategy.
Real-time access to congress intelligence enables companies to respond more quickly to scientific developments, physician feedback, and patient needs.
The platform is also expected to enhance compliance and data governance, ensuring information is captured in line with regulatory standards.
Driving Digital Transformation
Experts view the launch as part of a broader digital transformation across the life science sector, where artificial intelligence is increasingly used to improve efficiency and knowledge management.
By automating insight capture and analysis, Medical Congress AI helps bridge the gap between scientific exchange and business execution.
Overall, the innovation positions Virtual Science AI at the forefront of medical event intelligence, setting new standards for how congress insights are transformed into meaningful scientific and commercial outcomes.
-wilayah.com.my
